Cesar F. Vigo

Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis

Alfredo E. Rodríguez, Juan F. Granada, Máximo Rodriguez‐Alemparte et al. · Journal of the American College of Cardiology · 2006 · 97 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Oral Rapamycin +6

Pilot study of oral rapamycin to prevent restenosis in patients undergoing coronary stent therapy: Argentina Single-Center Study (ORAR Trial).

Alfredo E. Rodríguez, Máximo Rodríguez Alemparte, Cesar F. Vigo et al. · PubMed · 2003 · 45 citations

Pharmacotherapy, Surgery, Coronary Artery Disease +19

Efficacy and safety of a double‐coated paclitaxel‐eluting coronary stent: The EUCATAX trial

Alfredo E. Rodríguez, Cesar F. Vigo, Alejandro Delacasa et al. · Catheterization and Cardiovascular Interventions · 2010 · 14 citations · Full text

Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): Immediate and long-term results

Alfredo E. Rodríguez, Máximo Rodríguez Alemparte, Carlos Fernández Pereira et al. · American Heart Journal · 2005 · 11 citations

Long-term Results, Percutaneous Coronary Intervention, Endovascular Technique +10